✦ LIBER ✦

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer

✍ Scribed by Gibbs, D D; Pyle, L; Allen, M; Vaughan, M; Webb, A; Johnston, S R D; Gore, M E

Book ID: 109997222
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 90 KB
Volume: 86
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600250

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Optimal doses of paclitaxel and carbopla

Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study

✍ Tokai Gynecologic Oncology Group (Tokai GOG); K. Kuzuya; H. Ishikawa; T. Nakanis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 55 KB

A phase-I study evaluating the combinati

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

✍ Ruey-Long Hong; Ching-Hung Lin; Tsu-Yi Chao; Woei-You Kao; Cheng-Hsu Wang; Ruey 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 305 KB

Phase I dose and sequencing study of peg

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies

✍ Paula M. Fracasso; Luis C. Rodriguez; Thomas J. Herzog; Carole L. Fears; Sherry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and docetaxel have single‐agent activity in several malignancies. The authors conducted a Phase I trial to evaluate the maximum tolerated dose (MTD), toxicities, and effect of dose sequencing of this combination in patients with ad

Phase II multicenter open-label study of

Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

✍ L.H. LÊ; K.D. SWENERTON; L. ELIT; D.M. PROVENCHER; G.C.E. STUART; T. LE; U. LEE; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB